Article
Reversible inactivation of the transcriptional function of P53 protein by farnesylation.
BMC biotechnology - 29 May 2006
Couderc Bettina, Penary Marie, Tohfe Mustapha, Pradines Anne, Casteignau Antoine, Berg Danièle, Favre Gilles
Abstract excerpt
BACKGROUND: The use of integrating viral vectors in Gene therapy clinical trials has pointed out the problem of the deleterous effect of the integration of the ectopic gene to the cellular genome and the safety of this strategy. We proposed here a way to induce the death of gene modified cells upon request by acting on a pro-apoptotic protein cellular localization and on the activation of its apoptotic function....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
